The following article was originally published in Portuguese by Juliano Spyer in the Folha de S.Paulo newspaper in January 2024. I knocked on many doors looking for evangelicals who publicly defend the medicinal use of Cannabis. And I received two responses. Some people shrugged their shoulders, thinking that Christianity and marijuana are topics that don’t...
The following article, written by journalist Vanessa Adachi, was originally published in Portuguese by Reset on November 24th. Lawyer and businesswoman Patrícia Villela Marino doesn’t shy away from difficult conversations. As well as being an activist for the rights of women in and out of prison, she has also become one of the most vocal...
The president of the Humanitas360 Institute and advisor to the Institute for Social and Economic Research on Cannabis, Patrícia Villela Marino, participated on October 25th in the public hearing held by the Parliamentary Front for Medicinal Cannabis and Industrial Hemp, coordinated by deputy Caio França in the Legislative Assembly of the State of São Paulo....
This article was originally published in Portuguese on the Sechat website on February 12, 2023. The approval and subsequent sanction of the bill that provides for the supply of Cannabis-based medicines in the public health system in São Paulo is, above all, a victory of civil society. Serving as the driving force behind the parliamentary...
An important step towards democratizing access to the medicinal properties of cannabis was taken last Tuesday (31st) with the sanctioning of the bill that authorizes the supply of medicines made from the plant in the public health system in São Paulo. The approval is the result of the active citizenship of civil society, a struggle...
Our president Patrícia Villela Marino spoke with Veja magazine about the legalization of medical cannabis, one of her greatest struggles in the civic-social sphere. The article takes up stories portrayed in the documentary “Illegal” – produced by Villela Marino – and also highlights studies on the use of the drug in cases of patients living...